Abstract:
S. compound capsule is a proprietary herbal market formulation claimed to be used for treatment of osteoarthritis. It contains Sallaki
(Boswellia Serrata). Today there are requirements for modern routine quality control of botanical raw materials and finished
formulation in addition to the regular physical tests and identification. Hence in present study, an attempt was made to estimate
boswellic acid from S. compound. TLC fingerprinting profile of market formulation was performed and was compared with standard
Boswellic acid. Total organic acids as boswellic acid in formulation estimated by titrimetric method and were found to 64.42%. TLC
fingerprinting profile shows presence of eight bands in S. compound extract at Rf
0.13, 0.21, 0.26, 0.52, 0.57, 0.73. 0.76 and 0.99, it
was found to be comparable with standard boswellic acid. Hence, it was concluded that S compound contains Boswellic acid
